** Shares of drugmaker Ionis Pharmaceuticals IONS.O rise 6% to $31.65
** IONS ups 2025 sales forecast to $725 mln to $750 mln, up from prior forecast of at least $600 mln; analysts were expecting 2025 sales to be $659.7 mln - LSEG
** IONS posts Q1 sales of $132 mln vs analysts' est of $125.3 mln - LSEG
** IONS reports Q1 loss of 93 cents, compared with a loss of 98 cents a year ago
** As of last close, stock down 14.7% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。